Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3005 EUR | -3.06% | -4.15% | -22.95% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.95% | 13.9M | |
+67.91% | 62.86B | |
-0.79% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.68% | 26.46B | |
-23.02% | 18.9B | |
+4.81% | 12.67B | |
+23.48% | 12.27B | |
+27.85% | 12.07B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Pauses Early-Stage Colorectal Cancer Trial Amid Safety Issues